Author

Olusiji Alex Akinrinmade

Albert Einstein College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Anna SkwarskaiD· 1 shared Daohong ZhouiD· 1 shared Emmanouil ZacharioudakisiD· 1 shared Eugen DhimoleaiD· 1 shared Evripidis GavathiotisiD· 1 shared Francisco Madeira MarquesiD· 1 shared Guangrong ZhengiD· 1 shared Julio A. Aguirre‐GhisoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna SkwarskaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCellsPeer-reviewedOct 8, 2025

Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival

Sławomir Andrzejewski, Marie Winter, Leandro Encarnação Garcia…·Eugen Dhimolea

This study identifies OXPHOS-high quiescent triple-negative breast cancer cells that survive chemotherapy and depend on BCL-XL for survival, showing that targeting BCL-XL enhances chemotherapy efficacy.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky